In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.
British Skin Foundation walk us through the two main types of skin cancer, melanoma & non-melanoma, and the importance of funding research in the field.
The Canadian Institutes of Health Research (CIHR), a Canadian healthcare research investment agency, collaborates with partners to innovate health improvements.
Sean Lawler, Associate Professor at Brown University pursues an understanding of cancer through the lens of the molecular and cellular ecosystem and natural selection.
David Bloomfield, Consultant in Clinical Oncology Sussex Cancer Centre, argues that precision radiotherapy is our most effective cancer treatment and should be available to everyone with cancer, but workforce planning is failing our patients.
Marius Wellenstein, COO and co-Founder of WSK Medical, explains the successful launch and implementation of Zeno AI, a real-time AI solution for early throat cancer detection.
Asbestos in over 300,000 public sector buildings continues to put lives at risk. Recommendations to the government for its removal over the next 40 years have been ignored, says Liz Darlison of Mesothelioma UK and Helen Childs, Partner at RWK Goodman.
Common ingredients used in dyes, pigments and plastics can contain carcinogenic chemicals which could potentially harm child development if used by pregnant women.
A meta-analysis finds that women who breastfeed are less likely to develop heart conditions or diseases, or die from cardiovascular disease than women who do not breastfeed.
NHS cancer patients will be the first to experience drone chemotherapy, which furthers the NHS net zero strategy, as it cuts down travel time and distance.
